Effect of Xiqoyaosan on TLR-4/TRIF Signal Transduction Pathway in Rats of Non-alcoholic Fatty Hepatitis with Liver-Qi Stagnation and Spleen Deficiency Syndrome
LIU Yang, LI Ming-lei, JIA Fei, et al. Effect of Xiqoyaosan on TLR-4/TRIF Signal Transduction Pathway in Rats of Non-alcoholic Fatty Hepatitis with Liver-Qi Stagnation and Spleen Deficiency Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(17): 108-113.
LIU Yang, LI Ming-lei, JIA Fei, et al. Effect of Xiqoyaosan on TLR-4/TRIF Signal Transduction Pathway in Rats of Non-alcoholic Fatty Hepatitis with Liver-Qi Stagnation and Spleen Deficiency Syndrome[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(17): 108-113. DOI: 10.13422/j.cnki.syfjx.20181727.
Objective:To observe the effect of Xiaoyaosan on the activity of the Toll-like receptor-4(TLR-4)/TIR-domain-containing adapter-inducing interferon-β(TRIF) signal transduction pathway in liver cells of rats of non-alcoholic fatty hepatitis (NASH) with liver-Qi stagnation and spleen deficiency syndrome. Method:Thirty-two SPF grade SD male rats were selected and randomly divided into normal control group
model group
Xiaoyaosan treatment group and glycine treatment group (n=8). Except for the rats in normal control group
which were fed routinely with normal die
the NASH with the liver-Qi stagnation and the spleen deficiency syndrome experimental model were established in the rats of the other 3 groups with the ‘high-glucose and high-fat feed+irregular eating+chronic bondage stimulation’ method for 14 weeks. And then
normal saline
Xiaoyaosan solution (1 g·mL-1) and glycine solution (2.5 g·mL-1) were given by gavage for 4 weeks at the dosage of 2 mL·kg-1·d-1
3.24 mL·kg-1·d-1 and 2 mL·kg-1·d-1 in model group
Xiaoyaosan treatment group and glycine treatment group
respectively. The syndrome scores of liver-Qi stagnation and spleen deficiency were calculated
and the urine D-xylose excretion rate was detected in all of rats before being put to death
and the liver and brain tissues were extracted under aseptic and low temperature conditions. The content of norepinephrine (NE) and 5-serotonin (5-HT) in brain
the degree of steatosis and inflammatory cell infiltration and activity of TLR-4/TRIF signal transduction pathways in liver were detected with enzyme linked immunosorbent assay(ELISA)
htoxylin eosin(HE) staining and Real-time PCR
western blot technique. Result:Compared with the normal control group
increased syndrome scores of liver-Qi stagnation and spleen deficiency syndrome
declined urine D-xylose excretion rate and content of 5-HT and NE in brain
lots of fat vacuoles in hepatocyte cytoplasm and scattered spotty necrosis and inflammatory cells infiltration in hepatic lobular
increased TLR-4
TRIF mRNA and protein expressions in liver could be found in rats of model group (P<0.05). Compared with the model group
decreased syndrome scores of liver-Qi stagnation and spleen deficiency syndrome
elevated urine D-xylose excretion rate and content of 5-HT and NE in brain
alleviated steatosis and inflammatory cell infiltration
declined TLR-4
TRIF mRNA and protein expressions in liver could be found in rats of Xiaoyaosan treatment group and glycine treatment group (P<0.05). Conclusion:Xiaoyaosan could play the role in the treatment of NASH with liver-Qi stagnation and spleen deficiency syndrome by dispersing stagnated liver-qi
strengthening spleen and inhibiting activity of TLR-4/TRIF signal transduction pathway.